• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸格拉司琼在一次性弹性输液装置中的稳定性

Stability of granisetron hydrochloride in a disposable elastomeric infusion device.

作者信息

Chung K C, Chin A, Gill M A

机构信息

Department of Clinical Pharmacy, School of Pharmacy, University of Southern California (USC), Los Angeles 90033, USA.

出版信息

Am J Health Syst Pharm. 1995 Jul 15;52(14):1541-3. doi: 10.1093/ajhp/52.14.1541.

DOI:10.1093/ajhp/52.14.1541
PMID:7552896
Abstract

The stability and sterility of granisetron hydrochloride in 5% dextrose injection or 0.9% sodium chloride injection when stored in a disposable elastomeric infusion device were studied. Granisetron was diluted to 0.02 mg/mL (as the hydrochloride salt) in 5% dextrose chloride injection. The solution was placed in the drug reservoir of a disposable elastomeric infusion device and refrigerated at 4 degrees C for 14 days. A total of eight pumps were prepared, four containing granisetron 0.02 mg/mL in 5% dextrose injection and four containing granisetron 0.02 mg/mL in 0.9% sodium chloride injection. The solutions were assayed for granisetron concentration by stability-indicating high-performance liquid chromatography at 0 hours, 24 hours, 48 hours, 7 days, and 14 days. Each solution was inspected for clarity, color, and precipitation, and sterility testing was performed. Throughout the study, the mean concentration of granisetron remaining was more than 92% of the initial concentration both in 5% dextrose injection and in 0.9% sodium chloride injection. Individual solutions in 0.9% sodium chloride injection consistently maintained more than 90% of the initial drug concentration for only seven days. No microbial growth was detected. No precipitation, color change, or haziness was seen. Granisetron 0.02 mg/mL (as the hydrochloride salt) was stable and free of microbial growth in 0.9% sodium chloride injection for up to 7 days and stable and free of microbial growth in 5% dextrose injection for up to 14 days when stored at 4 degrees C in a disposable elastomeric infusion device.

摘要

研究了盐酸格拉司琼在储存在一次性弹性输液装置中时,于5%葡萄糖注射液或0.9%氯化钠注射液中的稳定性和无菌性。将格拉司琼在5%葡萄糖注射液中稀释至0.02 mg/mL(以盐酸盐计)。将该溶液置于一次性弹性输液装置的药库中,并在4℃下冷藏14天。共制备了8个泵,4个含有5%葡萄糖注射液中0.02 mg/mL的格拉司琼,4个含有0.9%氯化钠注射液中0.02 mg/mL的格拉司琼。通过稳定性指示高效液相色谱法在0小时、24小时、48小时、7天和14天时测定溶液中的格拉司琼浓度。检查每种溶液的澄清度、颜色和沉淀情况,并进行无菌测试。在整个研究过程中,5%葡萄糖注射液和0.9%氯化钠注射液中剩余格拉司琼的平均浓度均超过初始浓度的92%。0.9%氯化钠注射液中的个别溶液仅在7天内始终保持超过初始药物浓度的90%。未检测到微生物生长。未见沉淀、颜色变化或浑浊。当在一次性弹性输液装置中于4℃储存时,0.02 mg/mL(以盐酸盐计)的格拉司琼在0.9%氯化钠注射液中长达7天稳定且无微生物生长,在5%葡萄糖注射液中长达14天稳定且无微生物生长。

相似文献

1
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.盐酸格拉司琼在一次性弹性输液装置中的稳定性
Am J Health Syst Pharm. 1995 Jul 15;52(14):1541-3. doi: 10.1093/ajhp/52.14.1541.
2
Stability and compatibility of granisetron hydrochloride in i.v. solutions and oral liquids and during simulated Y-site injection with selected drugs.盐酸格拉司琼在静脉输液和口服液中的稳定性及与选定药物模拟 Y 型接口注射时的相容性。
Am J Health Syst Pharm. 1996 Feb 1;53(3):294-304. doi: 10.1093/ajhp/53.3.294.
3
Stability of granisetron hydrochloride in an extemporaneously prepared oral liquid.盐酸格拉司琼在临时配制的口服液中的稳定性。
Am J Health Syst Pharm. 1997 Jun 15;54(12):1404-6. doi: 10.1093/ajhp/54.12.1404.
4
Stability of doripenem in vitro in representative infusion solutions and infusion bags.多利培南在代表性输液溶液和输液袋中的体外稳定性。
Clin Ther. 2008 Nov;30(11):2075-87. doi: 10.1016/j.clinthera.2008.11.013.
5
Stability of doripenem in polyvinyl chloride bags and elastomeric pumps.多利培南在聚氯乙烯袋和弹性泵中的稳定性。
Am J Health Syst Pharm. 2010 Sep 15;67(18):1539-44. doi: 10.2146/ajhp090429.
6
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.盐酸格拉司琼在模拟 Y 型静脉给药过程中与选定药物的配伍性。
Am J Health Syst Pharm. 1997 Jan 1;54(1):56-60. doi: 10.1093/ajhp/54.1.56.
7
Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.盐酸昂丹司琼与甲泼尼龙琥珀酸钠在多层聚烯烃容器中的相容性。
Am J Health Syst Pharm. 2005 Oct 1;62(19):2001-5. doi: 10.2146/ajhp040446.
8
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.盐酸伐柔比星(VARUBI)注射用乳剂与静脉注射用盐酸格拉司琼混合后的相容性和稳定性
Int J Pharm Compd. 2018 Jan-Feb;22(1):86-94.
9
Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers.青霉素G钠用0.9%氯化钠注射液或5%葡萄糖注射液稀释后,储存在聚氯乙烯袋容器和弹性泵容器中的稳定性。
Am J Health Syst Pharm. 2014 Apr 15;71(8):669-73. doi: 10.2146/ajhp130440.
10
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers.头孢洛林酯在弹性家用输液系统和MINI-BAG Plus容器中的使用稳定性。
Int J Pharm Compd. 2015 Sep-Oct;19(5):432-6.

引用本文的文献

1
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron.晚期癌症患者的瘙痒症通过格拉司琼持续输注成功治愈。
Support Care Cancer. 2004 Mar;12(3):208-9. doi: 10.1007/s00520-003-0581-2. Epub 2004 Jan 21.